{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-209391","form_type":"8-K","ticker":"OKUR","cik":"0001637715","company_name":"OnKure Therapeutics, Inc.","filed_at":"2022-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.485266+00:00","generated_at":"2026-06-24T05:57:44.521437+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Reneo Pharmaceuticals appoints Roshawn Blunt as Class I director","bullets":["Roshawn Blunt appointed as Class I director effective August 2, 2022, term expiring at 2025 annual meeting.","She will receive $40,000 annual cash retainer and an initial option grant of 35,000 shares vesting over three years.","Further annual option grants of 17,500 shares, vesting by next annual meeting, with full acceleration on change in control."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-209391","json":"https://secwatch.observer/filing/0001193125-22-209391.json","markdown":"https://secwatch.observer/filing/0001193125-22-209391.md","text":"https://secwatch.observer/filing/0001193125-22-209391.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1637715/000119312522209391/0001193125-22-209391-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1637715/000119312522209391/d384999d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T05:57:44.521437+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0049319a6c","claim":"Roshawn Blunt was appointed as Class I Director at OnKure Therapeutics, Inc..","evidence_excerpt":"appointed Roshawn Blunt as a Class I director of the Company, with a term of office expiring at the 2025 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1637715/000119312522209391/0001193125-22-209391-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}